We are developing the Autem gEM device, which we believe may offer an additional option for the palliative care treatment in patients with advanced cancer. The treatment can be administered as monotherapy or in conjunction to standard of care.
Treatment consists of using radio-frequency electromagnetic fields modulated at patient specific frequencies (PSF) which cause improvement in quality of life and may extend survival, besides showing anti-proliferative effects in cancer cells.
Electromagnetic radiation is a common field of energy that surrounds us all the time, and it can be modulated in amplitude at specific and very low frequencies.
We believe that electromagnetic field gradients, generated by the Autem gEM device, cause substantial dielectrophoretic forces on tubulin dimers, microtubules and mitochondria. This results in intracellular kinetic and metabolic alterations besides the disruption of the mitotic spindle in cancer cells during mitosis.